bibliographic resource 861715 [br/861715]
https://w3id.org/oc/corpus/br/861715

is a

• document
• article

title

• Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival

publication date

• 2010-01-01

contributor

• https://w3id.org/oc/corpus/ar/2770798
• https://w3id.org/oc/corpus/ar/2770799
• https://w3id.org/oc/corpus/ar/2770800
• https://w3id.org/oc/corpus/ar/2770801
• https://w3id.org/oc/corpus/ar/2770802
• https://w3id.org/oc/corpus/ar/2770803
• https://w3id.org/oc/corpus/ar/2770804
• https://w3id.org/oc/corpus/ar/2770805
• https://w3id.org/oc/corpus/ar/2770806
• https://w3id.org/oc/corpus/ar/2770807
• https://w3id.org/oc/corpus/ar/2770808

format

• https://w3id.org/oc/corpus/re/387264

identifier

• https://w3id.org/oc/corpus/id/1420899
• https://w3id.org/oc/corpus/id/1420900
• https://w3id.org/oc/corpus/id/1420901

part of

• https://w3id.org/oc/corpus/br/77641